Arthritis

Report

5 Sep 2018
10

This report, commissioned by Arthritis New Zealand, highlights the staggering expenses associated with the direct, indirect, and for the first time, wellbeing costs of arthritis.

Briefing paper

14 Jul 2016
90

Summary

Musculoskeletal conditions are a range of conditions that affect the bones, muscles and connective tissues. In this bulletin, the musculoskeletal conditions reported include osteoarthritis; rheumatoid arthritis; osteoporosis; back problems; gout and other inflammatory arthropathies (in ammation of one or more joints); and...

Report

30 May 2016
38

A major new report shows the growing multi-billion dollar costs of arthritis to the economy, individuals and to the healthcare system and how relatively small investments could yield savings of more than $170 million a year.

Key findings of the report include: • There...

Journal article

7 Sep 2015
34

The research compared regional differences in the prevalence of rheumatic heart disease (RHD) detected by echocardiographic screening in high-risk Indigenous Australian children, and examined the logistical and other practical challenges of RHD screening. Thirty-two remote communities in four regions of northern and central Australia were...

Fact sheet

15 May 2015
180

This fact sheet summarises information from the AIHW's online musculoskeletal compendium.

Summary

Rheumatoid arthritis is a chronic disease marked by inflammation of the joints, most often affecting the hand joints and both sides of the body at the same time. It can...

Fact sheet

15 May 2015
500

This fact sheet summarises information from the AIHW's online musculoskeletal compendium.

Summary

Osteoarthritis is a degenerative condition mostly affecting the joints such as hips, knees and ankles. The main symptoms include pain, stiffness and limited joint movement which get worse over time....

Working paper

17 Oct 2014
74

This working paper uses the Australian Institute of Health and Welfare's recently developed assessment framework to assess the suitability of the Australian Rheumatology Association Database as a potential new data source for population health monitoring of inflammatory arthritis.

Summary

A wide range...

Report

13 Oct 2014
191

Executive summary: Arthritis Australia commissioned the Social Policy Research Centre (SPRC) at UNSW Australia to carry out research on the lived experience of people with arthritis related conditions. This report outlines the methods, findings and implications of the research.

Arthritis is the second...

Report

15 Aug 2014
89

Summary: This report provides information about Australia's health-care expenditure on arthritis and other musculoskeletal conditions, including that on patterns of expenditure by health-care sector, type of musculoskeletal condition, age group, sex and over time.

The main findings of the report are that, in...

Report

22 May 2014
75

This report assesses the potential for existing data sources to improve our understanding of arthritis and other musculoskeletal conditions and highlights future opportunities for improving data for monitoring these conditions.

Summary

Within the Australian population, arthritis and other musculoskeletal conditions are highly...

Report

16 May 2014
185

Arthritis and other musculoskeletal conditions affect an estimated 6.1 million Australians across all ages, this report finds.

Summary

Arthritis and other musculoskeletal conditions are common, affecting an estimated 6.1 million Australians (28% of the total population) in 2011-12. Due to their diverse...

Strategy

9 Apr 2014
205

The strategy outlined in this document provides a road map for improving care across Australia for people with arthritis and aims to reduce the costs to society of arthritis related diseases. The strategy is supported by three additional documents which respectively address the care of...

Thesis

6 Mar 2014
5

Gout is associated with various co-morbidities including insulin resistance and type 2 diabetes. Gout and type 2 diabetes are strongly linked to the individual components of metabolic syndrome. There may be shared pathogenic pathways between gout and type 2 diabetes in which insulin resistance, obesity,...

Report

27 Aug 2013
783

Key findings include:

$55.1 billion cost to the Australian economy, including direct health costs, lost productivity and reduced quality of life 6.1 million Australians already affected, of which 58% are of working age in peak income earning years (25-64 years) 43% growth in...

Thesis

2 Apr 2012
0

Gout and cardiovascular disease are both complex and multi-factorial with genetic predisposition and environmental triggers. Not only do both have high co-morbidity with other metabolic conditions, gout patients have high risk for cardiovascular events. Māori and Pacific populations have high risk for both gout and...

Thesis

24 Nov 2011
4

Gout is a common disease caused by immune response to monosodium urate (MSU) crystal deposition in articular or periarticular tissues and in the renal tract after chronic hyperuricemia (uric acid levels exceeding 7mg/dL). Gout generally progresses in three clinical stages: asymptomatic hyperuricemia (elevated serum urate...

Conference paper

14 Nov 2011
40

The Arthritis Map is a useful tool for people living with musculoskeletal conditions, health professionals, researchers, service providers and policy makers. It presents data in an efficient and easy-to-use format to improve prevention, self-management and service navigation. By providing indicators for service delivery needs across...

Thesis

6 Jul 2005
6

Gout is a debilitating arthritis caused by elevated levels of serum urate in the blood (hyperuricemia). The prevalence of gout is on the rise worldwide with particularly high rates of the disease present in Māori and Pacific populations in New Zealand (9.3-13.9% of Māori men...

Thesis

6 Jul 2005
2

Inflammatory arthritis (IA) is term that encompasses a range of auto-immune joint diseases that can cause severe pain, joint erosion and disability. Although there is no cure for these IAs, early treatment beginning within three months of symptom onset with disease-modifying anti-rheumatic drugs can significantly...

Overview

 

Items: 19